Medicare & Medicaid
The FDA has approved the first nonprescription OTC naloxone nasal spray, Narcan.
CMS has released a proposed rule to speed up prior authorization approval.
Lawmakers said the legislation would offer Medicare beneficiaries acesss to breakthrough medical devices.
Individuals can be assisted, "perhaps even literally while waiting for their clothes to dry," says UPMC for You president.
Value-based payment models by CMS have not yet resulted in significant savings to payers, providers or patients, says Health Affairs study.
Certified IDR entities have now resumed processing all payment determinations.
For acute care hospitals, the Medicare Advisory Payment Commission recommends a higher-than-current-law FFS payment update.
The first set of negotiations will occur during 2023 and 2024 and result in prices effective in 2026.
According to a recent report from HHS, 1,200 prescription drug prices increased faster than inflation in 2021.
Drug companies will pay rebates or face fines for raising prices faster than inflation.